HCA Healthcare, Inc. - 2002 Annual Report (10-K) Summary
Business Context and Reporting Period
This filing covers the fiscal year ended December 31, 2002. HCA Inc. is a leading U.S. health care services company operating 179 hospitals (166 general acute care, 6 psychiatric, 1 rehabilitation, and 6 joint ventures) and 78 freestanding surgery centers across 22 states, England, and Switzerland. The company's strategy focuses on cost-effective quality care, increasing facility utilization, and improving operating efficiencies through shared services and information system initiatives.
Key Financial Metrics
| Metric | 2002 | 2001 | 2000 |
|---|---|---|---|
| Revenues | $19,729 million | $17,953 million | $16,670 million |
| Net Income (Reported) | $833 million | $886 million | $219 million |
| Adjusted Net Income | $833 million | $955 million | $292 million |
| Diluted EPS (Reported) | $1.59 | $1.65 | $0.39 |
| Operating Cash Flow | $2,750 million | $1,413 million | $1,547 million |
| Total Assets | $18,741 million | $17,730 million | $17,568 million |
| Long-Term Debt | $6,943 million | $7,360 million | $6,752 million |
| Working Capital | $766 million | $957 million | $312 million |
Note: Adjusted Net Income excludes goodwill amortization, which ceased under SFAS 142 in 2002.
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 9.9% to $19.7 billion, driven by volume growth (1.2% increase in equivalent admissions) and an 8.6% increase in revenue per equivalent admission due to favorable managed care contract renewals.
- Government Settlement Charge: The most significant variance was a $603 million pretax charge ($418 million after-tax) recorded in Q4 2002. This resulted from a settlement understanding with the Department of Justice (DOJ) to resolve claims related to physician relations, cost reports, and wound care issues.
- Investment Impairment: The company recorded a $168 million other-than-temporary impairment charge on equity investment securities held by its insurance subsidiary due to market declines.
- Operating Expenses: Salaries and benefits remained stable as a percentage of revenue (40.3%), while the provision for doubtful accounts increased to 8.0% of revenue, reflecting higher bad debts from self-pay and uninsured patients.
Guidance, Outlook, Risks, and Unusual Items
- Government Investigations: HCA remains subject to ongoing investigations by the DOJ, CMS, and the SEC. While the DOJ settlement effectively ends the investigation initiated in 1997, it is subject to court approval. The company anticipates continued investigative activity in other jurisdictions.
- Medicare Outlier Payments: A proposed CMS rule change regarding outlier payment methodology could reduce monthly revenue from outlier payments by up to $12 million if finalized as proposed.
- Charity Care Policy Change: In March 2003, HCA announced plans to expand charity care eligibility. If applied retroactively to 2002, this would have reduced net revenue by approximately $325–$375 million and pretax income by $25 million.
- Capital Expenditures: Planned capital expenditures for 2003 and 2004 are expected to approximate $2.0 billion annually. The company also announced a definitive agreement to acquire the 14-hospital HealthMidwest system for $1.125 billion.
- Information Systems: Significant investments are underway for the Millennium Accounts Receivable System (MARS) and an Enterprise Resource Planning (ERP) system, with total estimated costs of $390 million and $320 million, respectively.
Key Facts for Investor Verification
- Settlement Finality: Verify the status of the DOJ and CMS settlement approvals and the execution of definitive written agreements, as the $603 million charge is contingent on these steps.
- Medicare Rule Impact: Monitor the finalization of the CMS outlier payment rule to assess the potential $12 million monthly revenue reduction.
- Charity Care Implementation: Confirm the CMS ruling on the new charity care policies and the timing of their implementation to gauge future revenue impacts.
- IRS Disputes: Review the status of ongoing IRS examinations and disputes totaling approximately $319 million in proposed taxes and interest.
- HealthMidwest Acquisition: Track regulatory approvals for the $1.125 billion acquisition of HealthMidwest.